TrialInternational journal of clinical practice2008

High doses of lercanidipine are better tolerated than other dihydropyridines in hypertensive patients with metabolic syndrome: results from the TOLERANCE study.

V Barrios et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.